Limited commercial value diminishes the likelihood of structural implementation of healthcare innovations

Innovation is often cited as one of the potential solutions to address challenges in healthcare. However, regardless of the value an innovation may hold for health and society, its structural implementation remains elusive if it lacks commercial potential. Valuable innovations, therefore, struggle to flourish. By shifting the focus of financing mechanisms from commercial value to societal value, encouraging the dissemination of innovations beyond local healthcare providers, and assisting innovators in conveying their ideas, valuable healthcare innovations can be better accomodated. This conclusion stems from a publication recently featured in Technology in Society by Medical Delta PhD candidate Sanne Allers and her colleagues from the Erasmus School of Health Policy & Management. The study is a result of the scientific program Medical Delta's Journey from Prototype to Payment . The research delves into the role of financing mechanisms in the process from development to the implementation of an innovation, as perceived from the innovators' perspective.